Literature DB >> 19292593

Oligomer-specific conformations of the human immunodeficiency virus (HIV-1) gp41 envelope glycoprotein ectodomain recognized by human monoclonal antibodies.

Wen Yuan1, Xing Li, Marta Kasterka, Miroslaw K Gorny, Susan Zolla-Pazner, Joseph Sodroski.   

Abstract

Trimerization of the human immunodeficiency virus (HIV-1) envelope glycoproteins is mediated by the ectodomain of the gp41 transmembrane glycoprotein. Here we investigate oligomer-specific conformations of gp41 by using monoclonal antibodies (MAbs) from HIV-1-infected humans. Human MAbs directed against the cluster I region of gp41 recognized trimeric, dimeric, and monomeric forms of soluble envelope glycoproteins; thus, the integrity of the cluster I epitopes is minimally affected by the oligomeric state. In contrast, human MAbs to the cluster II region were all oligomers specific. One cluster II MAb, 126-6, recognized exclusively the trimeric form of envelope glycoproteins, whereas the others recognized both trimeric and dimeric forms. Thus, a distinct trimer-specific conformation exists in the cluster II region of gp41. Analysis of soluble envelope glycoprotein mutants revealed that gp41 sequences immediately N-terminal to isoleucine 646 contribute to the formation of both the trimer and the trimer-specific conformational epitope.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19292593      PMCID: PMC2853836          DOI: 10.1089/aid.2008.0213

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  49 in total

1.  An alternative conformation of the gp41 heptad repeat 1 region coiled coil exists in the human immunodeficiency virus (HIV-1) envelope glycoprotein precursor.

Authors:  Claudia C Mische; Wen Yuan; Bettina Strack; Stewart Craig; Michael Farzan; Joseph Sodroski
Journal:  Virology       Date:  2005-07-20       Impact factor: 3.616

2.  Characterization of the multiple conformational States of free monomeric and trimeric human immunodeficiency virus envelope glycoproteins after fixation by cross-linker.

Authors:  Wen Yuan; Jessica Bazick; Joseph Sodroski
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies.

Authors:  Gary Frey; Hanqin Peng; Sophia Rits-Volloch; Marco Morelli; Yifan Cheng; Bing Chen
Journal:  Proc Natl Acad Sci U S A       Date:  2008-03-05       Impact factor: 11.205

4.  The reactivities of HIV-1+ human sera with solid-phase V3 loop peptides can be poor predictors of their reactivities with V3 loops on native gp120 molecules.

Authors:  J P Moore
Journal:  AIDS Res Hum Retroviruses       Date:  1993-03       Impact factor: 2.205

5.  A monoclonal Fab derived from a human nonimmune phage library reveals a new epitope on gp41 and neutralizes diverse human immunodeficiency virus type 1 strains.

Authors:  Elena Gustchina; John M Louis; Son N Lam; Carole A Bewley; G Marius Clore
Journal:  J Virol       Date:  2007-09-26       Impact factor: 5.103

Review 6.  AIDS virus envelope spike structure.

Authors:  Kenneth H Roux; Kenneth A Taylor
Journal:  Curr Opin Struct Biol       Date:  2007-03-28       Impact factor: 6.809

7.  Human immunodeficiency virus type 1 gp41 antibodies that mask membrane proximal region epitopes: antibody binding kinetics, induction, and potential for regulation in acute infection.

Authors:  S Munir Alam; Richard M Scearce; Robert J Parks; Kelly Plonk; Steven G Plonk; Laura L Sutherland; Miroslaw K Gorny; Susan Zolla-Pazner; Stacie Vanleeuwen; M Anthony Moody; Shi-Mao Xia; David C Montefiori; Georgia D Tomaras; Kent J Weinhold; Salim Abdool Karim; Charles B Hicks; Hua-Xin Liao; James Robinson; George M Shaw; Barton F Haynes
Journal:  J Virol       Date:  2007-10-17       Impact factor: 5.103

8.  Nature of nonfunctional envelope proteins on the surface of human immunodeficiency virus type 1.

Authors:  Penny L Moore; Emma T Crooks; Lauren Porter; Ping Zhu; Charmagne S Cayanan; Henry Grise; Paul Corcoran; Michael B Zwick; Michael Franti; Lynn Morris; Kenneth H Roux; Dennis R Burton; James M Binley
Journal:  J Virol       Date:  2006-03       Impact factor: 5.103

9.  A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein.

Authors:  S Jiang; K Lin; M Lu
Journal:  J Virol       Date:  1998-12       Impact factor: 5.103

Review 10.  Structure and function of the HIV envelope glycoprotein as entry mediator, vaccine immunogen, and target for inhibitors.

Authors:  Ponraj Prabakaran; Antony S Dimitrov; Timothy R Fouts; Dimiter S Dimitrov
Journal:  Adv Pharmacol       Date:  2007
View more
  20 in total

1.  Crystal structure of a non-neutralizing antibody to the HIV-1 gp41 membrane-proximal external region.

Authors:  Nathan I Nicely; S Moses Dennison; Leonard Spicer; Richard M Scearce; Garnett Kelsoe; Yoshihiro Ueda; Haiyan Chen; Hua-Xin Liao; S Munir Alam; Barton F Haynes
Journal:  Nat Struct Mol Biol       Date:  2010-11-14       Impact factor: 15.369

2.  Immunogenic Display of Purified Chemically Cross-Linked HIV-1 Spikes.

Authors:  Daniel P Leaman; Jeong Hyun Lee; Andrew B Ward; Michael B Zwick
Journal:  J Virol       Date:  2015-04-15       Impact factor: 5.103

3.  Nonneutralizing HIV-1 gp41 envelope cluster II human monoclonal antibodies show polyreactivity for binding to phospholipids and protein autoantigens.

Authors:  S Moses Dennison; Kara Anasti; Richard M Scearce; Laura Sutherland; Robert Parks; Shi-Mao Xia; Hua-Xin Liao; Miroslaw K Gorny; Susan Zolla-Pazner; Barton F Haynes; S Munir Alam
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

4.  Distinct conformational states of HIV-1 gp41 are recognized by neutralizing and non-neutralizing antibodies.

Authors:  Gary Frey; Jia Chen; Sophia Rits-Volloch; Michael M Freeman; Susan Zolla-Pazner; Bing Chen
Journal:  Nat Struct Mol Biol       Date:  2010-11-14       Impact factor: 15.369

5.  Comparison of Antibody-Dependent Cell-Mediated Cytotoxicity and Virus Neutralization by HIV-1 Env-Specific Monoclonal Antibodies.

Authors:  Benjamin von Bredow; Juan F Arias; Lisa N Heyer; Brian Moldt; Khoa Le; James E Robinson; Susan Zolla-Pazner; Dennis R Burton; David T Evans
Journal:  J Virol       Date:  2016-06-10       Impact factor: 5.103

6.  Trimerization of the HIV Transmembrane Domain in Lipid Bilayers Modulates Broadly Neutralizing Antibody Binding.

Authors:  Timothy M Reichart; Michael M Baksh; Jin-Kyu Rhee; Jason D Fiedler; Stephen G Sligar; M G Finn; Michael B Zwick; Philip E Dawson
Journal:  Angew Chem Int Ed Engl       Date:  2016-01-22       Impact factor: 15.336

7.  Modulating immunogenic properties of HIV-1 gp41 membrane-proximal external region by destabilizing six-helix bundle structure.

Authors:  Saikat Banerjee; Heliang Shi; Habtom H Habte; Yali Qin; Michael W Cho
Journal:  Virology       Date:  2016-01-21       Impact factor: 3.616

8.  Peptide Triazole Thiol Irreversibly Inactivates Metastable HIV-1 Env by Accessing Conformational Triggers Intrinsic to Virus-Cell Entry.

Authors:  Charles Gotuaco Ang; Erik Carter; Ann Haftl; Shiyu Zhang; Adel A Rashad; Michele Kutzler; Cameron F Abrams; Irwin M Chaiken
Journal:  Microorganisms       Date:  2021-06-12

Review 9.  Multiantibody strategies for HIV.

Authors:  Andrew Hiatt; Larry Zeitlin; Kevin J Whaley
Journal:  Clin Dev Immunol       Date:  2013-06-06

10.  Sub-inhibitory concentrations of human α-defensin potentiate neutralizing antibodies against HIV-1 gp41 pre-hairpin intermediates in the presence of serum.

Authors:  Lusine Demirkhanyan; Mariana Marin; Wuyuan Lu; Gregory B Melikyan
Journal:  PLoS Pathog       Date:  2013-06-13       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.